108 related articles for article (PubMed ID: 16713026)
1. Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors.
Marastoni M; Baldisserotto A; Trapella C; Gavioli R; Tomatis R
Eur J Med Chem; 2006 Aug; 41(8):978-84. PubMed ID: 16713026
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides.
Baldisserotto A; Franceschini C; Scalambra F; Trapella C; Marastoni M; Sforza F; Gavioli R; Tomatis R
J Pept Sci; 2010 Nov; 16(11):659-63. PubMed ID: 20814885
[TBL] [Abstract][Full Text] [Related]
3. P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors.
Marastoni M; Baldisserotto A; Trapella C; Gavioli R; Tomatis R
Bioorg Med Chem Lett; 2006 Jun; 16(12):3125-30. PubMed ID: 16603348
[TBL] [Abstract][Full Text] [Related]
4. Vinyl ester-based cyclic peptide proteasome inhibitors.
Baldisserotto A; Marastoni M; Fiorini S; Pretto L; Ferretti V; Gavioli R; Tomatis R
Bioorg Med Chem Lett; 2008 Mar; 18(6):1849-54. PubMed ID: 18294845
[TBL] [Abstract][Full Text] [Related]
5. Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit.
Baldisserotto A; Marastoni M; Trapella C; Gavioli R; Ferretti V; Pretto L; Tomatis R
Eur J Med Chem; 2007 May; 42(5):586-92. PubMed ID: 17291631
[TBL] [Abstract][Full Text] [Related]
6. Peptidyl vinyl ester derivatives: new class of selective inhibitors of proteasome trypsin-like activity.
Marastoni M; Baldisserotto A; Cellini S; Gavioli R; Tomatis R
J Med Chem; 2005 Jul; 48(15):5038-42. PubMed ID: 16033282
[TBL] [Abstract][Full Text] [Related]
7. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.
Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L
J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors.
Zhu Y; Yao S; Xu B; Ge Z; Cui J; Cheng T; Li R
Bioorg Med Chem; 2009 Oct; 17(19):6851-61. PubMed ID: 19747832
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors; synthesis and activity of arecoline oxide tripeptide derivatives.
Marastoni M; McDonald J; Baldisserotto A; Canella A; De Risi C; Pollini GP; Tomatis R
Bioorg Med Chem Lett; 2004 Apr; 14(8):1965-8. PubMed ID: 15050638
[TBL] [Abstract][Full Text] [Related]
10. A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo.
Verdoes M; Florea BI; Menendez-Benito V; Maynard CJ; Witte MD; van der Linden WA; van den Nieuwendijk AM; Hofmann T; Berkers CR; van Leeuwen FW; Groothuis TA; Leeuwenburgh MA; Ovaa H; Neefjes JJ; Filippov DV; van der Marel GA; Dantuma NP; Overkleeft HS
Chem Biol; 2006 Nov; 13(11):1217-26. PubMed ID: 17114003
[TBL] [Abstract][Full Text] [Related]
11. New cyclic peptide proteasome inhibitors.
Baldisserotto A; Marastoni M; Gavioli R; Tomatis R
Bioorg Med Chem Lett; 2009 Apr; 19(7):1966-9. PubMed ID: 19250821
[TBL] [Abstract][Full Text] [Related]
12. N-terminal-prolonged vinyl ester-based peptides as selective proteasome beta1 subunit inhibitors.
Baldisserotto A; Destro F; Vertuani G; Marastoni M; Gavioli R; Tomatis R
Bioorg Med Chem; 2009 Aug; 17(15):5535-40. PubMed ID: 19577931
[TBL] [Abstract][Full Text] [Related]
13. Novel CADD-based peptidyl vinyl ester derivatives as potential proteasome inhibitors.
Mou K; Xu B; Ma C; Yang X; Zou X; Lü Y; Xu P
Bioorg Med Chem Lett; 2008 Mar; 18(6):2198-202. PubMed ID: 18280155
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of boronic acid derivatives of tyropeptin: proteasome inhibitors.
Watanabe T; Momose I; Abe M; Abe H; Sawa R; Umezawa Y; Ikeda D; Takahashi Y; Akamatsu Y
Bioorg Med Chem Lett; 2009 Apr; 19(8):2343-5. PubMed ID: 19307118
[TBL] [Abstract][Full Text] [Related]
15. Alpha,beta-unsaturated N-acylpyrrole peptidyl derivatives: new proteasome inhibitors.
Baldisserotto A; Ferretti V; Destro F; Franceschini C; Marastoni M; Gavioli R; Tomatis R
J Med Chem; 2010 Sep; 53(17):6511-5. PubMed ID: 20687609
[TBL] [Abstract][Full Text] [Related]
16. C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors.
Baldisserotto A; Marastoni M; Lazzari I; Trapella C; Gavioli R; Tomatis R
Eur J Med Chem; 2008 Jul; 43(7):1403-11. PubMed ID: 17996987
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibition by peptide-semicarbazones.
Leban J; Blisse M; Krauss B; Rath S; Baumgartner R; Seifert MH
Bioorg Med Chem; 2008 Apr; 16(8):4579-88. PubMed ID: 18313310
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and inhibition study on tripeptide inhibitor modified poly(L-lysine) dendrimers.
Zhang X; Luo K; Wang G; Nie Y; He B; Wu Y; Gu Z
J Biomater Appl; 2012 Jul; 27(1):17-26. PubMed ID: 21123282
[TBL] [Abstract][Full Text] [Related]
19. Screening for selective small molecule inhibitors of the proteasome using activity-based probes.
Bogyo M
Methods Enzymol; 2005; 399():609-22. PubMed ID: 16338384
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach.
Vivier M; Rapp M; Papon J; Labarre P; Galmier MJ; Sauzière J; Madelmont JC
J Med Chem; 2008 Feb; 51(4):1043-7. PubMed ID: 18237109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
